🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.

Several experts stated the demand for retatrutide could be connected to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Content Removal

Based on TikTok, the service has removed violative material and banned associated keywords and search suggestions. The company said it was dedicated to maintaining the service safe and allocating resources in enhancing compliance measures.

Online Trading Activities

Research also discovered communities with up to nine thousand participants marketing retatrutide using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with numerous of users, filled with images of weight loss, positive reviews and step-by-step instructions for mixing or injecting at home.

After minutes of entering one group, a seller posted WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, health issues or past usage.

Item Information and Costs

Within these communities, posts show dark colored packages with Royal Mail stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens usually sold at £160 for 20mg. When questioned how much time a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service stated it regularly moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is valid, these online products may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her team has previously seen patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject users to potentially serious medical dangers”.